“…20 Although to the best of our knowledge very few of such systems have shown a satisfactory clinical effect, 3,11,21 tetraazamacrocycles, on the one side, and nanotechnology, on the other one, are arising as potential therapeutics for neurodegenerative disorders where oxidative stress is involved. 15–18,22–25 In this context, we have recently found that decoration of non-toxic boehmite nanoparticles (BNPs) with binuclear Cu 2+ azamacrocycles leads to a striking enhancement of the SOD activity of such complexes. 23,24,26 It should be finally taken into account that, despite the high value of the catalytic constant shown by the above-mentioned SOD mimetics, if they are not able to revert the generation of mHTT aggregates, such SOD scavengers would be of little use in the treatment of HD.…”